Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Amantadine and influenza A

R Dolin

    American Family Physician
    |January 1, 1979
    PubMed
    Summary

    Amantadine hydrochloride offers safe prophylaxis and treatment for influenza A. Its effective use requires prompt community influenza A detection, especially for high-risk, unvaccinated individuals.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A new ilio-femoro-tibial range of motion (IFT-ROM) test: reproducibility and effect of a passive stretching programme.

    Computer methods in biomechanics and biomedical engineering·2013
    Same author

    Kaiser Permanente's "metadata-driven" national clinical intranet.

    Studies in health technology and informatics·2001
    Same author

    Meta-analysis of five randomized controlled trials comparing continuation of zidovudine versus switching to didanosine in HIV-infected individuals.

    Antiviral therapy·2001
    Same author

    HIV vaccines for prevention of infection and disease in humans.

    Infectious disease clinics of North America·2001
    Same author

    A phase II study of two HIV type 1 envelope vaccines, comparing their immunogenicity in populations at risk for acquiring HIV type 1 infection. AIDS Vaccine Evaluation Group.

    AIDS research and human retroviruses·2000
    Same author

    Enterovirus 71--emerging infections and emerging questions.

    The New England journal of medicine·1999

    Area of Science:

    • Virology
    • Infectious Diseases
    • Pharmacology

    Background:

    • Amantadine hydrochloride is approved for influenza A prophylaxis and treatment.
    • Despite documented efficacy, U.S. utilization for influenza A has been limited.
    • The drug is generally well-tolerated and exhibits low toxicity.

    Purpose of the Study:

    • To evaluate the potential utility of amantadine hydrochloride in influenza A management.
    • To highlight its role in specific populations and the importance of timely diagnosis.

    Main Methods:

    • Review of clinical experience and efficacy data for amantadine hydrochloride.
    • Analysis of its safety and tolerability profile.
    • Assessment of optimal conditions for its therapeutic application.

    Main Results:

    • Amantadine hydrochloride demonstrates considerable clinical efficacy for influenza A.
    • It is well-tolerated and generally non-toxic.
    • Potential benefits exist for unvaccinated high-risk groups and essential personnel.

    Conclusions:

    • Amantadine hydrochloride remains a viable option for influenza A prophylaxis and treatment.
    • Its successful application hinges on the rapid identification of community influenza A outbreaks.
    • Consideration for high-risk, unvaccinated populations is warranted.

    Related Experiment Videos